RA Capital Management »

Rezolute shares owned by RA Capital Management

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $22M 9.2M 2.36

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Cidara Therapeutics SH (CDTX)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Vaxcyte SH (PCVX)
Sionna Therapeutics SH (SION)
Newamsterdam Pharma Co Nv SH (NAMS)
Tyra Biosciences SH (TYRA)
Wave Life Sciences SH (WVE)
Mineralys Therapeutics SH (MLYS)
Edgewise Therapeutics SH (EWTX)
Septerna SH (SEPN)
Nuvalent Inc-a SH (NUVL)
Disc Medicine SH (IRON)
Janux Therapeutics SH (JANX)

View all positions for RA Capital Management

Top funds holding Rezolute

Federated Investors
RA Capital Management
BlackRock
Opaleye Management
Vanguard Group
Balyasny Asset Management
State Street Corporation
UBS Group
Affinity Asset Advisors
FMR
Integral Health Asset Management
Geode Capital Management
Barclays
Millennium Management
Vestal Point Capital

View all funds holding Rezolute